Meyka Pro banner
Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. Fundamental Analysis (NASDAQ: CELZ)

CELZNASDAQ
HealthcareBiotechnology
$1.31
$0.19(16.96%)
U.S. Market opens in 37h 8m

Creative Medical Technology Holdings, Inc. Fundamental Analysis (NASDAQ: CELZ)

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) shows weak financial fundamentals with a PE ratio of -0.64, profit margin of -2013.55%, and ROE of -86.70%. The company generates $0.0B in annual revenue with weak year-over-year growth of -45.45%.

Key Strengths

Cash Position181.09%
PEG Ratio-0.01
Current Ratio12.91

Areas of Concern

ROE-86.70%
Operating Margin-2080.04%
We analyze CELZ's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -151121.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-151121.1/100

We analyze CELZ's fundamental strength across five key dimensions:

Efficiency Score

Weak

CELZ struggles to generate sufficient returns from assets.

ROA > 10%
-64.42%

Valuation Score

Excellent

CELZ trades at attractive valuation levels.

PE < 25
-0.64
PEG Ratio < 2
-0.01

Growth Score

Moderate

CELZ shows steady but slowing expansion.

Revenue Growth > 5%
-45.45%
EPS Growth > 10%
32.08%

Financial Health Score

Excellent

CELZ maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
12.91

Profitability Score

Weak

CELZ struggles to sustain strong margins.

ROE > 15%
-8669.51%
Net Margin ≥ 15%
-2013.55%
Positive Free Cash Flow
No

Key Financial Metrics

Is CELZ Expensive or Cheap?

P/E Ratio

CELZ trades at -0.64 times earnings. This suggests potential undervaluation.

-0.64

PEG Ratio

When adjusting for growth, CELZ's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Creative Medical Technology Holdings, Inc. at 0.55 times its book value. This may indicate undervaluation.

0.55

EV/EBITDA

Enterprise value stands at -1.98 times EBITDA. This is generally considered low.

-1.98

How Well Does CELZ Make Money?

Net Profit Margin

For every $100 in sales, Creative Medical Technology Holdings, Inc. keeps $-2013.55 as profit after all expenses.

-2013.55%

Operating Margin

Core operations generate -2080.04 in profit for every $100 in revenue, before interest and taxes.

-2080.04%

ROE

Management delivers $-86.70 in profit for every $100 of shareholder equity.

-86.70%

ROA

Creative Medical Technology Holdings, Inc. generates $-64.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

-64.42%

Following the Money - Real Cash Generation

Operating Cash Flow

Creative Medical Technology Holdings, Inc. generates limited operating cash flow of $-4.11M, signaling weaker underlying cash strength.

$-4.11M

Free Cash Flow

Creative Medical Technology Holdings, Inc. generates weak or negative free cash flow of $-4.11M, restricting financial flexibility.

$-4.11M

FCF Per Share

Each share generates $-1.59 in free cash annually.

$-1.59

FCF Yield

CELZ converts -1.75% of its market value into free cash.

-1.75%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.64

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.55

vs 25 benchmark

P/S Ratio

Price to sales ratio

1105.38

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

12.91

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.87

vs 25 benchmark

ROA

Return on assets percentage

-0.64

vs 25 benchmark

ROCE

Return on capital employed

-0.72

vs 25 benchmark

How CELZ Stacks Against Its Sector Peers

MetricCELZ ValueSector AveragePerformance
P/E Ratio-0.6430.97 Better (Cheaper)
ROE-86.70%515.00% Weak
Net Margin-201355.37%30197.00% Weak
Debt/Equity0.000.53 Strong (Low Leverage)
Current Ratio12.915.71 Strong Liquidity
ROA-64.42%-16.00% (disorted) Weak

CELZ outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Creative Medical Technology Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-99.91%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

99.60%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

67.23%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ